These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6137430)

  • 41. Structure-function relationships in pancreatic islets: support for intraislet modulation of insulin secretion.
    Hopcroft DW; Mason DR; Scott RS
    Endocrinology; 1985 Nov; 117(5):2073-80. PubMed ID: 2864239
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nervous control of pancreatic endocrine secretion in pigs. IV. The effect of somatostatin on the insulin and glucagon responses to electrical vagal stimulation and to intraarterial acetylcholine.
    Holst JJ; Grønholt R; Schaffalitzky de Muckadell OB; Fahrenkrug J
    Acta Physiol Scand; 1981; 113(3):273-8. PubMed ID: 6125083
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of cysteamine and antibody to somatostatin on islet cell function in vitro. Evidence that intracellular somatostatin deficiency augments insulin and glucagon secretion.
    Patel YC; Pierzchala I; Amherdt M; Orci L
    J Clin Invest; 1985 Apr; 75(4):1249-55. PubMed ID: 2859301
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of somatostatin on nonesterified fatty acid levels modifies glucose homeostasis during fasting.
    Hendrick GK; Frizzell RT; Cherrington AD
    Am J Physiol; 1987 Oct; 253(4 Pt 1):E443-52. PubMed ID: 2889364
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of acute hyperglycemia on the plasma C-peptide response to intravenous glucagon or to a mixed meal in insulin-dependent diabetes mellitus.
    Gjessing HJ; Reinholdt B; Faber OK; Pedersen O
    Acta Endocrinol (Copenh); 1991 May; 124(5):556-62. PubMed ID: 2028714
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The role of glucagon in hyperglycemia. A review (author's transl)].
    Luyckx A
    Diabete Metab; 1975 Sep; 1(3):201-8. PubMed ID: 791728
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics.
    Baron AD; Schaeffer L; Shragg P; Kolterman OG
    Diabetes; 1987 Mar; 36(3):274-83. PubMed ID: 2879757
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolic interactions of glucagon and cortisol in man--studies with somatostatin.
    Gill A; Johnston DG; Orskov H; Batstone GF; Alberti KG
    Metabolism; 1982 Apr; 31(4):305-11. PubMed ID: 6123061
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of glucagon-like peptide 1 (7-36 amide) on glucose kinetics during somatostatin-induced suppression of insulin secretion in healthy men.
    Shalev A; Ninnis R; Keller U
    Horm Res; 1998; 49(5):221-5. PubMed ID: 9568806
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of epinephrine on islet hormone secretion in the dog.
    Ahrén B; Veith RC; Taborsky GJ
    Int J Pancreatol; 1988 Jul; 3(5):375-88. PubMed ID: 2902147
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Extrapancreatic glucagon in control of glucose turnover in depancreatized dogs.
    Ross G; Lickley L; Vranic M
    Am J Physiol; 1978 Feb; 234(2):E213-19. PubMed ID: 623297
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of glucagon or somatostatin on desensitized insulin secretion.
    Bolaffi JL; Rodd G; Ma YH; Grodsky GM
    Endocrinology; 1990 Mar; 126(3):1750-5. PubMed ID: 1968383
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of a long acting glucagon selective somatostatin analogue on plasma glucose, insulin and glucagon levels in the anaesthetized rat during arginine infusion.
    Lien E; Sarantakis D
    Diabetologia; 1979 Jul; 17(1):59-64. PubMed ID: 467854
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Glucagon-like peptide 1 improves the ability of the beta-cell to sense and respond to glucose in subjects with impaired glucose tolerance.
    Byrne MM; Gliem K; Wank U; Arnold R; Katschinski M; Polonsky KS; Göke B
    Diabetes; 1998 Aug; 47(8):1259-65. PubMed ID: 9703326
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of glucagon on glucose production during insulin deficiency in the dog.
    Cherrington AD; Lacy WW; Chiasson JL
    J Clin Invest; 1978 Sep; 62(3):664-77. PubMed ID: 690190
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Somatostatin-28 is longer acting and more selective than somatostatin-14 on pituitary and pancreatic hormone release.
    Tannenbaum GS; Ling N; Brazeau P
    Endocrinology; 1982 Jul; 111(1):101-7. PubMed ID: 6123428
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of somatostatin (SRIF) on plasma glucose and insulin response to glucagon in liver cirrhosis.
    Altomonte L; Greco AV; Ghirlanda G; Rebuzzi AG; Manna R; Bertoli A
    Acta Diabetol Lat; 1979; 16(2):139-45. PubMed ID: 484163
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Importance of glucagon in mediating epinephrine-induced hyperglycemia in alloxan-diabetic dogs.
    Perez G; Kemmer FW; Lickley HL; Vranic M
    Am J Physiol; 1981 Oct; 241(4):E328-35. PubMed ID: 7032319
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Somatostatin-induced inhibition of insulin secretion from isolated islets of rat pancreas in presence of glucagon.
    Sieradzki J; Schatz H; Nierle C; Pfeiffer EF
    Horm Metab Res; 1975 Jul; 7(4):284-7. PubMed ID: 168138
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of morphine on glucose homeostasis in the conscious dog.
    Radosevich PM; Williams PE; Lacy DB; McRae JR; Steiner KE; Cherrington AD; Lacy WW; Abumrad NN
    J Clin Invest; 1984 Oct; 74(4):1473-80. PubMed ID: 6148357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.